Theriva Biologics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $13.0M | $10.0M |
| FY2013 | — | $15.2M | $14.6M |
| FY2014 | — | $9.6M | $17.5M |
| FY2015 | — | $16.1M | $20.8M |
| FY2016 | — | $3.8M | $19.1M |
| FY2017 | — | $-1.5M | $17.1M |
| FY2018 | — | $17.1M | $28.9M |
| FY2019 | — | $4.9M | $26.0M |
| FY2020 | — | $-4.8M | $6.2M |
| FY2021 | — | $65.4M | $67.3M |